Emory University’s AVEO Pharmaceuticals AVEO Stock Holding History
Bought
Maintained
Sold
Other funds holding AVEO
6CM
Emory University's AVEO Position: Q1 2018 in Review
Emory University sold out of AVEO Pharmaceuticals (AVEO) in Q1 2018, closing a stake of 60,288 shares — an estimated $1.68M sold.
Emory University first reported a position in AVEO in Q4 2017 and held it in 1 quarter. The position peaked at $1.68M in Q4 2017. 90 funds tracked by Wall St. Rank hold AVEO as of Q1 2018.
- Emory University reported no remaining AVEO Pharmaceuticals position as of Q1 2018 after selling out during the quarter.
- Emory University sold 60,288 AVEO Pharmaceuticals shares in Q1 2018, an estimated $1.68M.
- Emory University first reported a position in AVEO Pharmaceuticals in Q4 2017 and held it in 1 quarter.
- Emory University's AVEO Pharmaceuticals position peaked at $1.68M in Q4 2017.
- 90 funds tracked by Wall St. Rank held AVEO Pharmaceuticals as of Q1 2018.
Based on Emory University's 13F filing for Q1 2018, filed 14 May 2018.